These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 16151906)

  • 21. [Hereditary lysosomal diseases in Mexico. II. Laboratory diagnosis of mucopolysaccharidosis and mucolipidosis].
    Zetina ME; Gonzalez-Noriega A
    Rev Invest Clin; 1990; 42(3):165-73. PubMed ID: 2125355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butanolysis derivatization: improved sensitivity in LC-MS/MS quantitation of heparan sulfate in urine from mucopolysaccharidosis patients.
    Trim PJ; Hopwood JJ; Snel MF
    Anal Chem; 2015 Sep; 87(18):9243-50. PubMed ID: 26301744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
    Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
    Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
    de Ru MH; van der Tol L; van Vlies N; Bigger BW; Hollak CE; Ijlst L; Kulik W; van Lenthe H; Saif MA; Wagemans T; van der Wal WM; Wanders RJ; Wijburg FA
    J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urine samples.
    Piraud M; Boyer S; Mathieu M; Maire I
    Clin Chim Acta; 1993 Nov; 221(1-2):171-81. PubMed ID: 8149634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses.
    Lin HY; Lee CL; Lo YT; Wang TJ; Huang SF; Chen TL; Wang YS; Niu DM; Chuang CK; Lin SP
    Mol Genet Genomic Med; 2018 Nov; 6(6):982-992. PubMed ID: 30296009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Sakura N; Barrera L; Kida K; Kubota M; Orii T
    J Inherit Metab Dis; 2010 Apr; 33(2):141-50. PubMed ID: 20162367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses.
    Baydakova G; Ilyushkina A; Gaffke L; Pierzynowska K; Bychkov I; Ługowska A; Wegrzyn G; Tylki-Szymanska A; Zakharova E
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32183018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains.
    Ginsberg SD; Galvin JE; Lee VM; Rorke LB; Dickson DW; Wolfe JH; Jones MZ; Trojanowski JQ
    J Neuropathol Exp Neurol; 1999 Aug; 58(8):815-24. PubMed ID: 10446806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis.
    Maccari F; Galeotti F; Mantovani V; Zampini L; Padella L; Rigon L; Concolino D; Fiumara A; Pascale E; Pittalà A; Galeazzi T; Monachesi C; Marchesiello RL; Coppa G; Gabrielli O; Volpi N
    Anal Biochem; 2018 Sep; 557():34-41. PubMed ID: 30009765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe.
    Whitley CB; Spielmann RC; Herro G; Teragawa SS
    Mol Genet Metab; 2002 Jan; 75(1):56-64. PubMed ID: 11825064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Untargeted LC-HRMS metabolomics reveals candidate biomarkers for mucopolysaccharidoses.
    Torres CL; Scalco FB; de Oliveira MLC; Peake RWA; Garrett R
    Clin Chim Acta; 2023 Feb; 541():117250. PubMed ID: 36764508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic Discovery and Development of a Multiplexed Targeted MRM-LC-MS/MS Assay for Urine Biomarkers of Extracellular Matrix Disruption in Mucopolysaccharidoses I, II, and VI.
    Heywood WE; Camuzeaux S; Doykov I; Patel N; Preece RL; Footitt E; Cleary M; Clayton P; Grunewald S; Abulhoul L; Chakrapani A; Sebire NJ; Hindmarsh P; de Koning TJ; Heales S; Burke D; Gissen P; Mills K
    Anal Chem; 2015 Dec; 87(24):12238-44. PubMed ID: 26537538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis.
    Lin HY; Lo YT; Wang TJ; Huang SF; Tu RY; Chen TL; Lin SP; Chuang CK
    Sci Rep; 2019 Jul; 9(1):10755. PubMed ID: 31341247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractionation and characterization of urinary heparan sulfate excreted by patients with Sanfilippo syndrome.
    Kimura A; Hayashi S; Koseki M; Kochi H; Tsurumi K
    Tohoku J Exp Med; 1984 Nov; 144(3):227-36. PubMed ID: 6240800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans.
    Arunkumar N; Vu DC; Khan S; Kobayashi H; Ngoc Can TB; Oguni T; Watanabe J; Tanaka M; Yamaguchi S; Taketani T; Ago Y; Ohnishi H; Saikia S; Álvarez JV; Tomatsu S
    Diagnostics (Basel); 2021 Jul; 11(8):. PubMed ID: 34441282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucopolysaccharidoses and mucolipidoses.
    Wraith JE
    Handb Clin Neurol; 2013; 113():1723-9. PubMed ID: 23622395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycan-based biomarkers for mucopolysaccharidoses.
    Lawrence R; Brown JR; Lorey F; Dickson PI; Crawford BE; Esko JD
    Mol Genet Metab; 2014 Feb; 111(2):73-83. PubMed ID: 23958290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.